Tower Research Capital LLC (TRC) - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 87 filers reported holding G1 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$15,308
-13.7%
6,714
+63.6%
0.00%
Q1 2024$17,729
-4.7%
4,104
-32.7%
0.00%
Q4 2023$18,605
+59.6%
6,100
-24.6%
0.00%
Q3 2023$11,657
-86.5%
8,095
-76.6%
0.00%
-100.0%
Q2 2023$86,030
+373943.5%
34,550
+310.2%
0.00%
+200.0%
Q1 2023$23
-50.0%
8,423
+1.1%
0.00%
-50.0%
Q4 2022$46
-100.0%
8,328
-52.1%
0.00%
-50.0%
Q3 2022$217,000
+1569.2%
17,404
+549.4%
0.00%
Q2 2022$13,000
-86.3%
2,680
-78.7%
0.00%
-100.0%
Q1 2022$95,000
-62.3%
12,584
-49.0%
0.00%
-75.0%
Q4 2021$252,000
+54.6%
24,680
+103.7%
0.00%0.0%
Q3 2021$163,000
-45.5%
12,115
-11.1%
0.00%
-50.0%
Q2 2021$299,000
+647.5%
13,625
+718.8%
0.01%
+700.0%
Q1 2021$40,000
-78.5%
1,664
-83.9%
0.00%
-83.3%
Q4 2020$186,000
+226.3%
10,340
+111.6%
0.01%
+500.0%
Q3 2020$57,000
-51.7%
4,887
+0.7%
0.00%
-80.0%
Q2 2020$118,000
+413.0%
4,854
+133.4%
0.01%
+400.0%
Q1 2020$23,000
+475.0%
2,080
+1123.5%
0.00%
Q3 2019$4,0000.0%170
+112.5%
0.00%
Q3 2018$4,000
-86.2%
80
-93.1%
0.00%
-100.0%
Q3 2017$29,000
+222.2%
1,156
+110.6%
0.00%
+100.0%
Q2 2017$9,0005490.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders